REQUEST A DEMO
Total
USD $0.00
Search more companies

Grupofarma del Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Grupofarma del Ecuador S.A. Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Grupofarma del Ecuador S.A is an Ecuadorian pharmaceutical company. It offers a wide variety of medications for various therapeutic areas such as skin conditions, hyperthyroidism, acute pain, cardiovascular, gastrointestinal, gynecology, iron, vitamins, and urology. The company also provides nutritional supplements containing essential vitamins and minerals. Grupofarma del Ecuador S.A has developed and utilized various technologies for the development, manufacture, and marketing of their products. Their target market includes health professionals, patients, and users in Ecuador and the world's largest markets. They claim to have a strong presence in the pharmaceutical industry and operate in segments such as gastrointestinal, prenatal, and bone health.

Headquarters
Av. Naciones Unidas 1014, la Previsora, Torre a Bldg. , Floor 902
Quito; Pichincha;

Contact Details: Purchase the Grupofarma del Ecuador S.A. report to view the information.

Website: http://www.grupofarmadelecuador.com

Basic Information
Total Employees:
Purchase the Grupofarma del Ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Grupofarma del Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Grupofarma del Ecuador S.A. report to view the information.
Incorporation Date:
November 30, 1995
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Grupofarma del Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-13.3%
Total operating revenue
-13.3%
Operating profit (EBIT)
-98.03%
EBITDA
-93.89%
Net Profit (Loss) for the Period
N/A
Total assets
-19.62%
Total equity
-0.14%
Operating Profit Margin (ROS)
-68.58%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
9.74%
Quick Ratio
-1.06%
Cash Ratio
-0.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?